Loading...
XETR
M12
Market cap413mUSD
Jul 10, Last price  
18.10EUR
1D
-5.93%
1Q
15.58%
Jan 2017
71.65%
IPO
248.08%
Name

M1 Kliniken AG

Chart & Performance

D1W1MN
XETR:M12 chart
P/E
15.36
P/S
0.93
EPS
1.18
Div Yield, %
2.60%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
17.95%
Revenues
364m
+7.40%
6,081,00023,017,00034,926,33435,955,00047,194,52565,208,58677,216,857159,590,839314,610,275285,291,186316,318,613339,184,017364,298,940
Net income
22m
+38.17%
109,0004,585,0006,630,7555,007,4605,777,9716,612,5679,729,0306,823,0108,905,0914,317,35410,274,28316,018,45122,132,189
CFO
34m
+10.65%
-5,215,000912,575-171,7967,936,0002,085,9642,860,919-3,524,3119,540,66915,658,05520,768,8717,809,46230,545,87133,799,277
Dividend
Jul 17, 20250.5 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

M1 Kliniken AG, a Berlin, Germany-based entity established in 2007 and operating as a subsidiary of MPH Health Care AG, manages medical facilities dedicated to aesthetic and plastic surgery across Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company's operations are segmented into two core divisions: Beauty and Trade. The Beauty segment is responsible for the creation and commercialization of pharmaceutical, medical, and medical technology products tailored for aesthetic medicine and cosmetic dermatology. Meanwhile, the Trade segment engages in the distribution of pharmaceuticals, biosimilars, and other medical products and devices, serving critical therapeutic areas such as oncology, HIV, rheumatology, neurology, cardiovascular conditions, and narcotics. Products are supplied to healthcare professionals, pharmacies, and wholesale distributors under the "M1 Select" brand. M1 Kliniken AG's operational footprint encompasses a network of outpatient specialist centers, a specialized surgical clinic center, and 46 distinct specialist locations branded as "M1 Med Beauty." Additionally, the company is involved in the acquisition, administration, and divestiture of real estate, predominantly within the healthcare industry.
IPO date
Sep 14, 2015
Employees
366
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT